Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique R Perez

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|March 23, 2019
Clioquinol: To harm or healDominique R Perez, Larry A Sklar, Alexandre Chigaev
SLAS Discovery : Advancing Life Sciences R & D|May 30, 2018
High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreenDominique R Perez, Bruce S Edwards, Larry A Sklar, et al.
Seminars in Cancer Biology|February 12, 2020
Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunityDominique R Perez, Larry A Sklar, Alexandre Chigaev, et al.
Oncotarget|April 30, 2016
Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemiaDominique R Perez, Yelena Smagley, Matthew Garcia, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|March 23, 2019
Clioquinol: To harm or healDominique R Perez, Larry A Sklar, Alexandre Chigaev
SLAS Discovery : Advancing Life Sciences R & D|May 30, 2018
High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreenDominique R Perez, Bruce S Edwards, Larry A Sklar, et al.
Seminars in Cancer Biology|February 12, 2020
Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunityDominique R Perez, Larry A Sklar, Alexandre Chigaev, et al.
Oncotarget|April 30, 2016
Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemiaDominique R Perez, Yelena Smagley, Matthew Garcia, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Pageof 1